Evidence map›Paper›PMID 31994907›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2020

Increased particle flow rate from airways precedes clinical signs of ARDS in a porcine model of LPS-induced acute lung injury.

Martin Stenlo, Snejana Hyllén, Iran A N Silva, Deniz A Bölükbas, Leif Pierre, Oskar Hallgren, Darcy E Wagner, Sandra Lindstedt

3 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04503057 unknown statusnot on this map

Exhaled Breath Particles as a Clinical Indicator for Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) in Coronavirus (Covid-19) Positive and Negative Patients

Typeobservational_patient_registrySponsorLund University HospitalRan2020 to 2025Enrolled300ConditionsCovid19, ARDS, Human, ALI
NCT05375149 recruitingnot on this map

Exhaled Breath Particles as a Clinical Indicator for Acute and Chronic Rejection After Lung Transplantation

TypeobservationalSponsorLund University HospitalRan2018 to 2026Enrolled150ConditionsLung Transplant Rejection, Primary Graft Dysfunction, Chronic Rejection of Lung Transplant
NCT05395611 unknown statusnot on this map

Exhaled Breath Particles as Biomarkers for Diagnosing, Prognosticating and Evaluating of Non Small Cell Lung Cancer

TypeobservationalSponsorLund University HospitalRan2018 to 2025Enrolled300ConditionsLung Cancer, Non-small Cell Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung CancerArmsEBPcollected using the PExA device.
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Machine Perfusion and Bioengineering Strategies in Transplantation-Beyond the Emerging Concepts.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Martin StenloDepartment of Cardiothoracic Anaesthesia and Intensive Care and Cardiothoracic Surgery and Transplantation, Skåne University Hospital, Lund University, Lund, Sweden.
Snejana HyllénDepartment of Cardiothoracic Anaesthesia and Intensive Care and Cardiothoracic Surgery and Transplantation, Skåne University Hospital, Lund University, Lund, Sweden.
Iran A N SilvaDepartment of Experimental Medical Sciences, Lung Bioengineering and Regeneration, Lund University, Lund, Sweden.
Deniz A BölükbasDepartment of Experimental Medical Sciences, Lung Bioengineering and Regeneration, Lund University, Lund, Sweden.
Leif PierreDepartment of Cardiothoracic Anaesthesia and Intensive Care and Cardiothoracic Surgery and Transplantation, Skåne University Hospital, Lund University, Lund, Sweden.
Oskar HallgrenWallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
Darcy E WagnerDepartment of Experimental Medical Sciences, Lung Bioengineering and Regeneration, Lund University, Lund, Sweden.ORCID 0000-0003-3794-1309
Sandra LindstedtDepartment of Cardiothoracic Anaesthesia and Intensive Care and Cardiothoracic Surgery and Transplantation, Skåne University Hospital, Lund University, Lund, Sweden.ORCID 0000-0003-4484-6473
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute respiratory distress syndrome (ARDS) is a common cause of death in the intensive care unit, with mortality rates of ~30-40%. To reduce invasive diagnostics such as bronchoalveolar lavage and time-consuming in-hospital transports for imaging diagnostics, we hypothesized that particle flow rate (PFR) pattern from the airways could be an early detection method and contribute to improving diagnostics and optimizing personalized therapies. Porcine models were ventilated mechanically. Lipopolysaccharide (LPS) was administered endotracheally and in the pulmonary artery to induce ARDS. PFR was measured using a customized particles in exhaled air (PExA 2.0) device. In contrast to control animals undergoing mechanical ventilation and receiving saline administration, animals who received LPS developed ARDS according to clinical guidelines and histologic assessment. Plasma levels of TNF-α and IL-6 increased significantly compared with baseline after 120 and 180 min, respectively. On the other hand, the PFR significantly increased and peaked 60 min after LPS administration, i.e., ~30 min before any ARDS stage was observed with other well-established outcome measurements such as hypoxemia, increased inspiratory pressure, and lower tidal volumes or plasma cytokine levels. The present results imply that PFR could be used to detect early biomarkers or as a clinical indicator for the onset of ARDS.

Indexed as

Disease Models, AnimalPulmonary Gas ExchangeAcute Lung InjuryAnimalsBlood Gas AnalysisCytokinesHemodynamicsLipopolysaccharidesParticle SizeRespiratory Distress SyndromeRheologySwineTidal VolumeCytokinesLipopolysaccharidesARDSLPS-induced lung injurymechanical ventilationparticles in exhaled air

Identifiers

PMID31994907
PMCPMC7191636
OpenAlexW3003527182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.